We are monitoring the impact of COVID-19 on North America Cancer Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2147
Share on
Share on

North America Cancer Biomarkers Market Research Report - Segmented By Disease, Services, Application, Type, Region (the United States, Canada and Rest of North America) – Size, Share, Trends, Growth, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2147
Pages: 145

North America Cancer Biomarkers Market Size (2021 to 2026)

The North American Cancer Biomarkers Market size was worth USD 4.85 billion in 2021 and is estimated to be growing at a CAGR of 10.9% to reach USD 8.13 billion by 2026 during the forecast period.

The significant factors that are fuelling the growth of cancer biomarker are the occurrence of cancer due to increasing rate in consumption of tobacco, unhealthy food habits, frequent exposure to UV and sunlight metabolic mutation, genetic mutation and hormonal imbalance, and rise in demand for early diagnosis and rise in the geriatric population.

Growing adoption of biomarkers in drug target developments and surrogate endpoints, increasing focus on research and progress due to advancements of technology, data augmentation, and growing investments also contribute to the growth of the North American cancer biomarkers market.

The factors limiting the cancer biomarkers market's growth are reimbursements and regulations, biomarker techniques are high expensive, reluctance in adopting new technologies, and low detection rate.

Companion diagnostics and personalized medicines are the specialized fields expanding growth opportunities for the cancer biomarkers market. In addition to this, increasing occurrence of breast and prostate cancers, growing investments owing to ease of government regulations and technological advancements, adoption of biomarkers for detecting tumors, drug development and discovery, in cancer therapies for tracking responses are expected to provide lucrative opportunities for the growth of North America Cancer Biomarkers market. 

This research report on the North America Cancer Biomarkers Market segmented and sub-segmented into the following categories:

By Disease: 

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Other Cancers

By Services: 

  • Sample Preparation
  • Assay Development
  • Biomarkers Validation
  • Testing

By Application: 

  • Risk Assessment
  • Development of Molecular Diagnostics
  • Disease Diagnosis
  • Drug Discovery & Development
  • Drug Formulation

By Type: 

  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Biomarkers

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, North America accounted for the largest share in the Global Cancer Biomarkers Market.

The U.S. Cancer Biomarkers Market is anticipated to hold the largest share in the North American market as a result of the increasing necessity for investment in research and development, embellishing the constant rate of cancer, augmenting the government assistance for the discovery and advancing of biomarkers and acquiring advanced technologies for biomarkers. One million seven hundred thirty-five thousand three hundred fifty new cancer cases were diagnosed, and 609,640 deaths occurred due to cancer in this country, according to the American Cancer Society in 2018. According to the American Cancer Society's analysis report, nearly 234,030 new lung cancer cases were recorded, and about 154,050deaths occurred due to lung cancer.

The Canadian cancer biomarkers market is next to the U.S., leading the majority share in the North American market. It is expected to grow with a CAGR of 11.4% during the forecast period. Canada has a population of 36 million in 2018, which records for 0.48% of the world's total population. The elder people population anticipates the Canadian market, a large patient pool diagnosed with cancer. Lung cancer is the leading segment that causes more death in Canada. Around 21% of new cancer cases in men are diagnosed with prostate cancer, 58 men will be diagnosed with prostate cancer every day, whereas 11men will be reduced from prostate cancer every day. Out of 2, 1 will have cancer, and out of 4, 1will die due to cancer, which is reported according to the Canadian Cancer Reports.

Leading companies operating in the North American Cancer Biomarkers Market profiled in this report are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A, Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 Prostate Cancer    

                                5.1.3 Breast Cancer        

                                5.1.4 Lung Cancer            

                                5.1.5 Colorectal Cancer 

                                5.1.6 Cervical Cancer      

                                5.1.7 Other Cancers       

                                5.1.8  Y-o-Y Growth Analysis, By Disease               

                                5.1.9  Market Attractiveness Analysis, By Disease             

                                5.1.10  Market Share Analysis, By Disease            

                5.2 Services                       

                                5.2.1 Introduction           

                                5.2.2 Sample Preparation            

                                5.2.3 Assay development            

                                5.2.4 Biomarkers validation and testing 

                                5.2.5  Y-o-Y Growth Analysis, By Services              

                                5.2.6  Market Attractiveness Analysis, By Services            

                                5.2.7  Market Share Analysis, By Services             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Risk Assessment   

                                5.3.3 Development of molecular diagnostics       

                                5.3.4 Disease diagnosis 

                                5.3.5 Drug discovery      

                                5.3.6 Development and Drug formulation            

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Type                              

                                5.4.1 Introduction           

                                5.4.2 Protein Biomarkers             

                                5.4.3 Genetic biomarkers            

                                5.4.4 genetic biomarkers             

                                5.4.7  Y-o-Y Growth Analysis, By Type    

                                5.4.8  Market Attractiveness Analysis, By Type  

                                5.4.9  Market Share Analysis, By Type    

                5.5 Profiling Technologies                            

                                5.5.1 Omics technologies             

                                                5.5.1.1 Genomics

                                                5.5.1.2 Proteomics

                                                5.5.1.3 Metabolomics

                                                5.5.1.4 Transcriptomics

                                                5.5.1.5 Pharmacogenomics

                                5.5.2 Imaging technologies         

                                5.5.3 Immunoassays      

                                5.5.4 Cytogenetics          

                                5.5.5 Bioinformatics       

                                5.5.6 IVD multivariate index assays         

                                5.5.7  Y-o-Y Growth Analysis, By Profiling Technologies  

                                5.5.8  Market Attractiveness Analysis, By Profiling Technologies                

                                5.5.9  Market Share Analysis, By Profiling Technologies  

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Services

                                                6.1.3.4 By Application

                                                6.1.3.5 By Type

                                                6.1.3.6 Profiling Technologies

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Services

                                                6.1.4.4 By Application

                                                6.1.4.5 By Type

                                                6.1.4.6 Profiling Technologies

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Services

                                                6.1.5.4 By Application

                                                6.1.5.5 By Type

                                                6.1.5.6 Profiling Technologies

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Agendia Bv                 

                8.3 Biocurex Inc                               

                8.4 Biomerieux S.A.                        

                8.5 Biomoda Inc                               

                8.6 Astellas Pharma Us Inc                          

                8.7 Correlogic Systems Inc                           

                8.8 Beckman Coulter Inc                              

                8.9 Becton                          

                8.10 Dickinson And Company                     

                8.11 Clarient Inc                               

                8.12 Diadexus Inc                            

                8.13 Ambrilia Biopharma                              

                8.14 Affymetrix Inc                         

                8.15 Aureon Laboratories Inc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  2. North America Prostate Cancer Market, By Region, From 2021 to 2026 (USD Million)
  3. North America Breast Cancer Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Lung Cancer Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Cervical Cancer  Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Other Cancers Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  9. North America Sample Preparation Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Assay development  Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Biomarkers validation and testing Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  13. North America Risk Assessment Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Development of molecular diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Disease diagnosis Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Drug discovery  Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Development and Drug formulation Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  19. North America Protein Biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  20. North America Genetic biomarkers  Market, By Region, From 2021 to 2026 (USD Million)
  21. North America Other biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  23. North America Omics technologies  Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Imaging technologies Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Cytogenetics Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Bioinformatics Market, By Region, From 2021 to 2026 (USD Million)
  28. North America IVD multivariate index assays Market, By Region, From 2021 to 2026 (USD Million)
  29. United States Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  30. United States Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  31. United States Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  32. United States Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  33. United States Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  34. Canada Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  35. Canada Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  36. Canada Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  37. Canada Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  38. Canada Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  39. North America Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)
  40. North America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  41. North America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  42. North America Metabolomics Market, By Region, From 2021 to 2026 (USD Million)
  43. North America Transcriptomics Market, By Region, From 2021 to 2026 (USD Million)
  44. North America Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Million)
  45. United States Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)
  46. Canada Cancer Biomarkers Market, By Omics technologies , From 2021 to 2026 (USD Million)

 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample